Literature DB >> 3774930

SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

J Levine, N R Schooler.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3774930

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  127 in total

1.  What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?

Authors:  Jackie K Gollan; Maurizio Fava; Benji Kurian; Stephen R Wisniewski; A John Rush; Ella Daly; Sachiko Miyahara; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2011-12-06       Impact factor: 6.505

2.  Measurement-based care for unipolar depression.

Authors:  David W Morris; Madhukar H Trivedi
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

3.  Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder.

Authors:  Helmut Niederhofer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Jonathan D Huppert; Shawn Cahill; Michael J Maher; Carmen P McLean; James Bender; Sue M Marcus; Monnica T Williams; Jamie Weaver; Donna Vermes; Page E Van Meter; Carolyn I Rodriguez; Mark Powers; Anthony Pinto; Patricia Imms; Chang-Gyu Hahn; Raphael Campeas
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

5.  A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.

Authors:  Christopher W Kahler; Patricia A Cioe; Golfo K Tzilos; Nichea S Spillane; Lorenzo Leggio; Susan E Ramsey; Richard A Brown; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2017-05-07       Impact factor: 3.455

6.  Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Authors:  Marlene P Freeman; George I Papakostas; Bettina Hoeppner; Erica Mazzone; Heidi Judge; Cristina Cusin; Sanjay Mathew; Gerard Sanacora; Dan Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2019-01-08       Impact factor: 4.791

7.  Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

Authors:  Lorenzo Leggio; William H Zywiak; Samuel R Fricchione; Steven M Edwards; Suzanne M de la Monte; Robert M Swift; George A Kenna
Journal:  Biol Psychiatry       Date:  2014-03-25       Impact factor: 13.382

8.  Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.

Authors:  Angeli Landeros-Weisenberger; Antonio Mantovani; Maria G Motlagh; Pedro Gomes de Alvarenga; Liliya Katsovich; James F Leckman; Sarah H Lisanby
Journal:  Brain Stimul       Date:  2014-12-03       Impact factor: 8.955

9.  Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Authors:  Barbara J Mason; John M Light; Lauren D Williams; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

10.  Pharmacokinetics and Pharmacodynamics of Immediate-Release Versus Extended-Release Guanfacine in Adult Daily Smokers.

Authors:  Terril L Verplaetse; Walter Roberts; Kelly E Moore; MacKenzie R Peltier; Lindsay M Oberleitner; Sherry A McKee
Journal:  J Clin Psychopharmacol       Date:  2019 Mar/Apr       Impact factor: 3.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.